[Results of therapy of resistant urinary tract infections with urovalidine].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000779:Anesthetics, Local / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001391:Azo Compounds / Q000627:therapeutic use*; D003523:Cycloserine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010621:Phenazopyridine / Q000627:therapeutic use; D011704:Pyelonephritis / Q000188:drug therapy*; D011725:Pyridines / Q000627:therapeutic use*
D000779:Anesthetics, Local; D000900:Anti-Bacterial Agents; D001391:Azo Compounds; D011725:Pyridines; D003523:Cycloserine; D010621:Phenazopyridine
Výsledky terapie rezistentni infekce mocových cest urovalidinem.